The accumulation of amyloid beta plaques in the brain is a defining pathology of Alzheimer’s disease
In clinical trials, ADUHELM reduced amyloid beta plaques by 59 to 71 percent at 18 months of treatmentContinue reading
The accumulation of amyloid beta plaques in the brain is a defining pathology of Alzheimer’s disease
In clinical trials, ADUHELM reduced amyloid beta plaques by 59 to 71 percent at 18 months of treatmentContinue reading
Results to be presented at 2021 ASCO Annual Meeting demonstrate that Abemaciclib and LY3214996 achieve pharmacologically-relevant concentrations in Gd-non-enhancing GBM tissue • Ongoing study will accrue an additional 25 patients at the Optimal Time Interval (OTI) identified for tissue samplingContinue reading
The acquisition provides the companies with shared scientific knowledge and resources, leading to a stronger foundation for advancing newborn stem cell researchContinue reading
Heidi Jannenga, one of Arizona’s most accomplished health-care-technology entrepreneurs, has been elected to the Flinn Foundation board of directors. Continue reading
Washington, DC, USA (June 3rd, 2021): Virgin Galactic has announced a new contract to fly International Institute of Astronautical Sciences (IIAS) researcher Kellie Gerardi on a test flight of the company’s spaceflight system, during which Kellie will conduct experiments and test new healthcare technologies (including the Astroskin Bio-Monitor) while she’s in space. Continue reading
It is challenging to find anyone who has not had their life impacted by cancer, a debilitating illness, or a degenerative condition. These diseases affect not only the patient’s life, but those of their families and their surrounding community. The advancement of medicine is changing this trajectory, and that advancement will go right through Phoenix.Continue reading
Phoenix, Arizona, June 1, 2021 – The University of North Dakota (UND) Center for Family Medicine (CFM) in Bismarck is partnering with Beacon Biomedical Inc. to study a new blood-based colorectal cancer (CRC) screening test, called BeScreened-CRC, for North Dakota patients.Continue reading
State-of-the-art facility designed to support medical research, learning and entrepreneurshipContinue reading
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform
Accelerates Caris’ rapid growth as the market leader reshaping precision oncology through basic science research and the application of artificial intelligence to one of the largest clinico-genomic databases
Capital raise represents one of the largest private financings in precision medicine supported by a diverse, high-quality syndicate of leading investorsContinue reading
The ASA Castle Biosciences Research Grant Melanoma was awarded to Joel Sunshine, M.D., Ph.D., Johns Hopkins School of Medicine